Oxtoby Andrew has filed 3 insider transactions across 1 company since March 2025.
Most recent transaction: a grant/award of 222000 shares of Kalaris Therapeutics, Inc. ($KLRS) on March 19, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 19, 2026 | Kalaris Therapeutics, Inc. | $KLRS | Oxtoby Andrew | See Remarks | A | Stock Option (Right to Buy) | 222000 | $0.00 | 222,000.0000 | 18,702,418 | 9999.99% | 1.19% |
| April 10, 2025 | Kalaris Therapeutics, Inc. | $KLRS | Oxtoby Andrew | See Remarks | A | Stock Option (Right to Buy) | 287000 | $0.00 | 287,000.0000 | 5,043,357 | 9999.99% | 5.69% |
| March 18, 2025 | Kalaris Therapeutics, Inc. | $KLRS | Oxtoby Andrew | See Remarks | A | Stock Option (right to buy) | 476611 | $0.00 | 476,611.0000 | 5,043,357 | 9999.99% | 9.45% |